title: Targeting schistosome histone modifying enzymes for drug development.
abstract: The histone modifying enzymes (HME) represent particularly promising targets for the development of alternatives to praziquantel, the only currently available drug to combat schistosomiasis. The inhibition of these enzymes frequently arrests the cell cycle or induces apoptosis in cancer cells, but not in normal cells and numerous HME inhibitors are under investigation as potential anticancer agents. The recent resolution of the genome sequences of Schistosoma mansoni and Schistosoma japonicum has allowed us to identify all the schistosome genes encoding histone acetyltransferases, deacetylases, methyltransferases and demethylases. We have chosen a strategy using phylogenetic screening with inhibitors of HME classes, screening of individual HME targets by both high-throughput and reasoned (in silico docking using resolved crystal structures) approaches in a project funded by the European Community, named SEtTReND (Schistosome Epigenetics: Targets, Regulation, New Drugs). The initial focus is on the class I histone deacetylase (HDAC) 8 since the comparison of the catalytic site of the schistosome and human enzymes shows crucial differences, rendering possible the development of inhibitors specific for SmHDAC8. However, phenotypic screening shows that inhibitors of all HME classes tested were able to induce apoptosis and death in parasites in vitro, indicating that other enzymes may prove to be viable targets.
authors.affiliation: CIIL, Institut Pasteur de Lille, F-59019 Lille, France. raymond.pierce@pasteur-lille.fr
authors.forename: Raymond J
authors.initials: RJ
authors.lastname: Pierce
authors.forename: Florence
authors.initials: F
authors.lastname: Dubois-Abdesselem
authors.forename: Julien
authors.initials: J
authors.lastname: Lancelot
authors.forename: Luiza
authors.initials: L
authors.lastname: Andrade
authors.forename: Guilherme
authors.initials: G
authors.lastname: Oliveira
mesh_terms: D000818:Animals; D015195:Drug Design; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use*; D006657:Histones / Q000378:metabolism*; D006801:Humans; D012547:Schistosoma / Q000187:drug effects* / Q000254:growth & development / Q000378:metabolism*; D012552:Schistosomiasis / Q000188:drug therapy*; D012556:Schistosomicides / Q000627:therapeutic use*
chemical_list: D056572:Histone Deacetylase Inhibitors; D006657:Histones; D012556:Schistosomicides